Wissenschaftliche Arbeiten
Prof. Dr. Saadettin Kılıçkap
479 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.
-
Mitteilungen · Reports
Breast Care, 2013
DOI 10.1159/000312547 Frei zugänglicher VolltextQuelle: OpenAlex
-
Interview
Breast Care, 2013
DOI 10.1159/000299865 Frei zugänglicher VolltextQuelle: OpenAlex
-
Aromatase inhibitors and safety: Clinical or statistical significance?
Journal of Clinical Oncology, 2013
DOI 10.1200/jco.2013.49.2884 PMID 23918949 1 Zitation (Europe PMC) Quelle: ORCID
-
Dose-dense effect: Other contributors
The Lancet Oncology, 2013
DOI 10.1016/s1470-2045(13)70466-2 PMID 24176565 Quelle: ORCID
-
Effect of endocrine therapy on quality of life and cognitive functions in patients with breast cancer
Breast Care, 2013
DOI 10.1159/000350780 PMID 24419304 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Evaluation of quality of life in Turkish patients with head and neck cancer
Asian Pacific Journal of Cancer Prevention, 2013
DOI 10.7314/apjcp.2013.14.8.4805 PMID 24083748 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Increasing performance of a hospital-based cancer registry: Hacettepe university hospitals experience
Journal of B.U.ON., 2013
PMID 24344044 3 Zitationen (OpenAlex) Quelle: ORCID
-
Smoking habits of relatives of patients with cancer: Cancer diagnosis in the family is an important teachable moment for smoking cessation
Asian Pacific Journal of Cancer Prevention, 2013
DOI 10.7314/apjcp.2013.14.1.475 PMID 23534777 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Therapeutic proteins in tumors and targeted therapeutic agents for cancer patients
Protein and Peptide Letters, 2013
DOI 10.2174/092986652012131112123040 PMID 24261978 1 Zitation (Europe PMC) Quelle: ORCID
-
Metastasis to Pleura of Malignant Trichilemmal Tumor
Respiratory Case Reports, 2013
DOI 10.5505/respircase.2013.81300 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
Peripheral Neuropathy in Sézary Syndrome: Coincidence or a Part of the Syndrome?
Turkish Journal of Hematology, 2013
DOI 10.4274/tjh.2012.0163 PMID 24385837 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
Evre IV küçük hücreli dışı akciğer kanserli hastaların sağkalımını etkileyen faktörler
Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi, 2013
DOI 10.7197/1305-0028.1975 2 Zitationen (OpenAlex) Quelle: OpenAlex
-
Non-metastatik mide kanserli olgularda prognostik faktörler
Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi, 2013
DOI 10.7197/1305-0028.1900 1 Zitation (OpenAlex) Quelle: OpenAlex
-
Baş boyun kanserli hastalarda tedavi sonuçları ve prognostik faktörler
Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi, 2013
DOI 10.7197/1305-0028.1744 1 Zitation (OpenAlex) Quelle: OpenAlex
-
Düşük frekanslı elektromanyetik alan, cep telefonları, baz istasyonları ve kanser riski
DergiPark (Istanbul University), 2013
DOI 10.7197/cmj.v35i2.1008000887 Quelle: OpenAlex
-
Benign pheochromocytoma associated with colorectal cancer: Case report
Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi, 2013
DOI 10.7197/1305-0028.1895 Quelle: OpenAlex
-
Evre IV küçük hücreli dışı akciğer kanserli hastaların sağkalımını etkileyen faktörler
DergiPark (Istanbul University), 2013
Quelle: OpenAlex
-
Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy: Morbidity and Mortality Analysis of Our Patients
Turkiye Klinikleri Journal of Medical Sciences, 2012
DOI 10.5336/medsci.2011-23538 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever
Journal of Vector Borne Diseases, 2012
DOI 10.4103/0972-9062.213375 PMID 22898483 45 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID
-
Chemotherapy-induced spontaneous orgasms in a patient with breast cancer
Annals of Pharmacotherapy, 2012
DOI 10.1345/aph.1p666 PMID 22215688 1 Zitation (Europe PMC) Quelle: ORCID
-
Clinical characteristics, treatment and survival outcomes in malignant mesothelioma: Eighteen years' experience in Turkey
Asian Pacific Journal of Cancer Prevention, 2012
DOI 10.7314/apjcp.2012.13.11.5735 PMID 23317248 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme
Acta Oncologica, 2012
DOI 10.3109/0284186x.2011.644251 PMID 22201408 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Insulin therapy and cancer-specific mortality in patients with colorectal cancer and diabetes
Journal of Clinical Oncology, 2012
DOI 10.1200/jco.2011.41.4391 PMID 22493418 Quelle: ORCID
-
Long-term complications in Hodgkin's lymphoma survivors
Tumori, 2012
DOI 10.1177/030089161209800510 PMID 23235755 4 Zitationen (Europe PMC) Quelle: ORCID
-
Paclitaxel, not bevacizumab, was primarily responsible for the favorable effects seen in the RIBBON-2 trial
Journal of Clinical Oncology, 2012
DOI 10.1200/jco.2011.40.2305 PMID 22203773 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Prognosis of colorectal cancer with peritoneal carcinomatosis: Is a new staging necessary?
Journal of Clinical Oncology, 2012
DOI 10.1200/jco.2012.42.1701 PMID 22614990 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Screening colonoscopy participation in Turkish colorectal cancer patients and their first degree relatives
Asian Pacific Journal of Cancer Prevention, 2012
DOI 10.7314/apjcp.2012.13.6.2829 PMID 22938467 11 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Serum levels of alpha-tocopherol, vitamin C, beta-carotene, and retinol in malignant pleural mesothelioma
Asian Pacific Journal of Cancer Prevention, 2012
DOI 10.7314/apjcp.2012.13.7.3025 PMID 22994705 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
The effect of sorafenib in postoperative adhesion formation in a rat uterine horn model
Clinical and Experimental Obstetrics and Gynecology, 2012
PMID 23157042 2 Zitationen (OpenAlex) Quelle: ORCID
-
Bevacizumab (BEV) plus capecitabine as maintenance therapy after initial treatment with BEV plus XELOX in previously untreated patients (pts) with metastatic colorectal cancer (mCRC): Mature data from STOP and GO, a phase III, randomized, multicenter study.
Journal of Clinical Oncology, 2012
DOI 10.1200/jco.2012.30.15_suppl.3565 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
The association between socio-demographic parameters and the use of complementary interventions in cancer patients in Turkey: A Turkish Oncology Group study
journal of cancer therapeutics and research, 2012
DOI 10.7243/2049-7962-1-33 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
Prognostic Factors that Affect the Survival of Gastric Cancer
Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi, 2012
DOI 10.7197/1305-0028.1191 1 Zitation (OpenAlex) Quelle: OpenAlex
-
Association of higher proliferation of Ki67 with unfavorable prognostic factors and shorter survival in breast cancer.
Journal of Clinical Oncology, 2012
DOI 10.1200/jco.2012.30.15_suppl.e11083 1 Zitation (OpenAlex) Quelle: OpenAlex
-
Clinical characteristics, treatment and survival outcomes in malignant mesothelioma
European Respiratory Journal, 2012
Quelle: OpenAlex
-
AFTER THE SIXTH YEAR SCALP METASTASIS ISOLATED CASE OF BREAST CANCER DIAGNOSIS
DOAJ (DOAJ: Directory of Open Access Journals), 2012
Quelle: OpenAlex
-
risetoheterogeneitywithinthesetwogroupsaswellasamisinterpretation ofresults,especiallybecauseofthelessertumorburdeninthenonpcCRC groupinthisstudy.ItistypicaltoexpectashorterOSandDFSinagroup with a lower tumor burden. In addition, the number of patients with
2012
Quelle: OpenAlex
-
Smoking habits of relatives of patients (pts) with cancer.
Journal of Clinical Oncology, 2012
DOI 10.1200/jco.2012.30.15_suppl.9050 Frei zugänglicher VolltextQuelle: OpenAlex
-
Assessment of the life quality in head and neck cancer patients.
Journal of Clinical Oncology, 2012
DOI 10.1200/jco.2012.30.15_suppl.e16005 Quelle: OpenAlex
-
Effect of the patient's age on radiotherapy-based adverse effect.
Journal of Clinical Oncology, 2012
DOI 10.1200/jco.2012.30.15_suppl.e19575 Quelle: OpenAlex
-
Antitumor and Antiangiogenic Activity of Sorafenib on Colorectal Cancer
Annals of Oncology, 2012
DOI 10.1016/s0923-7534(20)33127-6 Frei zugänglicher VolltextQuelle: OpenAlex
-
Beyin tümörlü hastaların radyoterapi sonrası retrospektif değerlendirilmesi
Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi, 2012
DOI 10.7197/1305-0028.1570 Quelle: OpenAlex
-
Multipl primer malign neoplaziler: Cumhuriyet Üniversitesi verileri
Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi, 2012
DOI 10.7197/1305-0028.1417 Quelle: OpenAlex
-
Benign pheochromocytoma associated with colorectal cancer: Case report
DergiPark (Istanbul University), 2012
Quelle: OpenAlex
-
Non-metastatik mide kanserli olgularda prognostik faktörler
DergiPark (Istanbul University), 2012
Quelle: OpenAlex
-
Primary pericardial malignant mesothelioma: A rare but aggressive disease
DergiPark (Istanbul University), 2012
Quelle: OpenAlex
-
Frequency of cancer types in patients aged 65 and older: Results from cancer registry database of hacettepe university hospitals,65 yaş ve üzeri̇ popülasyonda kanser sikli&inin da&ilimi: Hacettepe üni̇versi̇tesi̇ hastaneleri̇ kanser kayit si̇stemi̇ sonuçlari
Turk Geriatri Dergisi, 2011
Quelle: ORCID
-
Gastric cancer after cadaveric liver transplantation in a patient with autoimmune hepatitis: A case report and review of the literature
Turkish Journal of Gastroenterology, 2011
DOI 10.4318/tjg.2011.0160 PMID 21480115 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
The First line systemic chemotherapy in metastatic gastric carcinoma: A comparison of Docetaxel, Cisplatin and Fluorouracil (DCF) versus Cisplatin and Fluorouracil (Cf); versus Epirubicin, Cisplatin and Fluorouracil (ECF) regimens in clinical setting
Hepato-Gastroenterology, 2011
PMID 21510316 12 Zitationen (OpenAlex) Quelle: ORCID
-
A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer.
Journal of Clinical Oncology, 2011
DOI 10.1200/jco.2011.29.4_suppl.474 2 Zitationen (OpenAlex) Quelle: OpenAlex
-
65 Yaş ve üzeri popülasyonda kanser sıklığının dağılımı: Hacettepe Üniversitesi Hastaneleri kanser kayıt sistemi sonuçları
AYBU AVESIS, 2011
1 Zitation (OpenAlex) Quelle: OpenAlex